To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 43,027 shares, the number of shares held increased 2.17% compared to the previous period and now represents 2.09% of the total position.
      75Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 8,245 shares, the number of shares held increased 2.16% compared to the previous period and now represents 2.25% of the total position.
      65Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 62,458 shares, the number of shares held increased 2.17% compared to the previous period and now represents 3.77% of the total position.
      76Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 226,270 shares, the number of shares held increased 2.17% compared to the previous period and now represents 1.45% of the total position.
      7.04K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 101,252 shares, the number of shares held increased 2.17% compared to the previous period and now represents 1.53% of the total position.
      152Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 20,553 shares, the number of shares held increased 2.17% compared to the previous period and now represents 2.88% of the total position.
      17Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 255 shares, the number of shares held increased 2.14% compared to the previous period and now represents 0.97% of the total position.
      34Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 42,636 shares, the number of shares held increased 2.17% compared to the previous period and now represents 9.99% of the total position.
      113Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 107,950 shares, the number of shares held increased 2.17% compared to the previous period and now represents 1.96% of the total position.
      26Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-17 07:13
      ARKG Investment Tracker position change: Increased position in Natera by 4,998 shares, the number of shares held increased 2.16% compared to the previous period and now represents 4.39% of the total position.
      34Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed